Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial

Long, GV (author)

Stroyakovskiy, D (author)

Gogas, H (author)

show more...

Levchenko, E (author)

de Braud, F (author)

Larkin, J (author)

Garbe, C (author)

Jouary, T (author)

Hauschild, A (author)

Grob, JJ (author)

Chiarion-Sileni, V (author)

Lebbe, C (author)

Mandala, M (author)

Millward, M (author)

Arance, A (author)

Bondarenko, I (author)

Haanen, JBAG (author)

Hansson, J (author)

Karolinska Institutet

Utikal, J (author)

Ferraresi, V (author)

Kovalenko, N (author)

Mohr, P (author)

Probachai, V (author)

Schadendorf, D (author)

Nathan, P (author)

Robert, C (author)

Ribas, A (author)

DeMarini, DJ (author)

Irani, JG (author)

Swann, S (author)

Legos, JJ (author)

Jin, F (author)

Mookerjee, B (author)

Flaherty, K (author)

show less...

 (creator_code:org_t)

2015

2015

English.

In: Lancet (London, England). - 1474-547X. ; 386:9992, s. 444-451

Related links:

http://kipublication...

show more...

https://doi.org/10.1...

show less...

• Journal article (peer-reviewed)